Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2010
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267732 Prognostic Molecular Markers for ET-743 Treatment
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267654 Rifamycin derivatives
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267642 Use of complex forms of calmodulin-like skin protein clsp
10/21/2010US20100267641 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof
10/21/2010US20100267626 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
10/21/2010US20100267622 Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100267586 siRNA targeting KRAS
10/21/2010US20100267585 Chemical ligation dependent probe amplification (CLPA)
10/21/2010US20100267582 Differential expression of molecules associated with acute stroke
10/21/2010US20100267576 Compositions And Methods For Identifying And Treating Subjects At Risk Of Developing Type 2 Diabetes
10/21/2010US20100267574 Predicting lung cancer survival using gene expression
10/21/2010US20100267573 Methods for In Vivo Identification of Endogenous mRNA Targets of MicroRNAs
10/21/2010US20100267572 Space efficient polymer sets
10/21/2010US20100267571 Novel method for specimen preparation, which ensures preservation of tissue morphology and nucleic acid quality
10/21/2010US20100267569 Compositions, methods and kits for the diagnosis of carriers of mutations in the BRCA1 and BRCA2 genes and early diagnosis of cancerous disorders associated with mutations in BRCA1 and BRCA2 genes
10/21/2010US20100267566 Active Substances for Increasing the Stress Defense in Plants to Abiotic Stress, and Methods of Finding Them
10/21/2010US20100267128 Compositions and method for use in isolation of nucleic acid molecules
10/21/2010US20100267120 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267119 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267083 Modified Cytochrome P450 Monooxygenases
10/21/2010US20100267080 Reagent for blood analysis and method of use thereof
10/21/2010US20100267079 Identification and isolation of transitional cell carcinoma stem cells
10/21/2010US20100267078 Selective Detection of Proteins that Contain Two or More Alpha-Helical Transmembrane Domains
10/21/2010US20100267077 method of measuring the ability of a sample to withstand reactive oxygen species (ross)
10/21/2010US20100267076 Separation of Co-Cultivated Cell Populations
10/21/2010US20100267075 Microfluidic lysis
10/21/2010US20100267074 Measurement and uses of oxidative stress
10/21/2010US20100267073 Stem cell-based culture system for drug development
10/21/2010US20100267072 Formation/Elongation of Axon by Inhibiting the Expression or Function of Singar and Application to Nerve Regeneration
10/21/2010US20100267071 Solution phase homogeneous assays
10/21/2010US20100267070 Pharmaceutical compositions for the treament of conditions responsive to proteasome inhibition
10/21/2010US20100267069 Analysis of proteins from biological fluids using mass spectrometric immunoassay
10/21/2010US20100267068 Analysis of doping compounds
10/21/2010US20100267067 Synthase Inhibitor Screening Method
10/21/2010US20100267066 Microchip and blood monitoring device
10/21/2010US20100267065 Apparatus and methods for analyzing fluid variables
10/21/2010US20100267062 Osteopontin as Novel Prognostic Biomarker for Heart Failure
10/21/2010US20100267061 Detecting phospholipidosis and diagnosing lysosomal storage disorders
10/21/2010US20100267053 Akt3 polypeptides
10/21/2010US20100267051 Annexin for cancer risk assessment
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100267045 Cudr as biomarker for cancer progression and therapeutic response
10/21/2010US20100267044 Genetically engineered biological indicator
10/21/2010US20100267043 System and method for identification of individual samples from a multiplex mixture
10/21/2010US20100267042 Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance
10/21/2010US20100267041 Serial analysis of biomarkers for disease diagnosis
10/21/2010US20100267040 MN/CA IX and Cancer Prognosis
10/21/2010US20100267039 Method of differentiating coccidioides species
10/21/2010US20100267038 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae
10/21/2010US20100267037 Genotoxicity as a biomarker for inflammation
10/21/2010US20100267036 Polymorphism identification method
10/21/2010US20100267035 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
10/21/2010US20100267034 Markers for prenatal diagnosis and monitoring
10/21/2010US20100267033 Methods and Compositions For Detecting Autoimmune Disorders
10/21/2010US20100267032 Prediction of Likelihood of Cancer Recurrence
10/21/2010US20100267031 Method of Screening for RAGE-Amyloid-Beta Peptide Interaction Inhibiting Materials
10/21/2010US20100267030 Systems and methods for measuring translation activity in viable cells
10/21/2010US20100267029 Method of identifying the plant species of the genus uncaria
10/21/2010US20100267028 Tgfbr1 HAPLOINSUFFICIENCY MODIFIES RISK FOR CANCER
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267026 Methods and apparatus for characterizing polynucleotides
10/21/2010US20100267025 Methods and compositions for the assessment of cardiovascular function and disorders
10/21/2010US20100267024 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
10/21/2010US20100267023 Selective restriction fragment amplification: fingerprinting
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267021 Methods for determining cytosine methylation in dna and uses thereof
10/21/2010US20100267020 Genetic risk factor for neurodegenerative disease
10/21/2010US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin
10/21/2010US20100267018 Oligonucleotide analogues
10/21/2010US20100267017 Monitoring real-time pcr with label free intrinsic imaging
10/21/2010US20100267016 Transgenic microbial polyhydroxyalkanoate producers
10/21/2010US20100267015 Nucleic acid detection
10/21/2010US20100267014 Method for Prognosis of a Response to a Treatment
10/21/2010US20100267013 Methods to increase nucleotide signals by raman scattering
10/21/2010US20100267012 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/21/2010US20100267011 Method and apparatus for detecting nucleic acids using bead and nanopore
10/21/2010US20100267010 Method and Apparatus for Real-Time Analysis of Chemical, Biological and Explosive Substances in the Air
10/21/2010US20100267009 Method for the in vitro diagnosis and/or in vitro therapy monitoring of infections
10/21/2010US20100267008 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/21/2010US20100267007 Solid-fluid composition and uses thereof
10/21/2010US20100267006 Method for detection of cirulent strain of influenza type-a virus
10/21/2010US20100267005 Crosslinking Within Coordination Complexes
10/21/2010US20100267004 Method, Substances and Kits for Labeling Population of RNA and Other Substances Containing Vicinal Diols
10/21/2010US20100267003 Methods and kit for endometriosis screening
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266680 Treatment of Cancer Using TLR3 Agonists
10/21/2010US20100266677 Nucleic acid binding compounds and methods of use
10/21/2010US20100266627 Allelic exchange mutagenesis in map
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266618 Compositions and methods for augmenting activity of oncolytic viruses
10/21/2010US20100266615 D1-1 nucleic acids, polypeptides and related methods
10/21/2010US20100266602 Method for Diagnosing Rheumatoid Arthritis via Assaying Myofibroblast-Like Synoviocytes for Fibroblast Activation Protein
10/21/2010US20100266600 Methods of using il-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive t cells
1 ... 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 ... 3003